The Time-Restricted Intake of Meals Study
Status: | Recruiting |
---|---|
Conditions: | Obesity Weight Loss, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 21 - 69 |
Updated: | 10/18/2018 |
Start Date: | September 24, 2018 |
End Date: | December 2020 |
Contact: | Nisa M Maruthur |
Email: | maruthur@jhmi.edu |
Phone: | 14105028896 |
The Time-Restricted Intake of Meals Study: A Randomized, Controlled Feeding Study
TRIM is a randomized, controlled feeding study to evaluate if eating earlier in the day vs.
later in the day impacts weight and glucose homeostasis.
later in the day impacts weight and glucose homeostasis.
Inclusion Criteria:
- Prediabetes defined by HbA1c 5.7-6.4%, or type 2 diabetes with HbA1c 6.5-6.9%
- Class I-III obesity (BMI 30-39.9 kg/m2)
- If on medications for hypertension, stable regimen for at least past 6 months
- Willingness to adjust timing of feeding
- Willingness and ability to eat study diet and nothing else during run-in and
intervention
- Willingness to complete measurement procedures
Exclusion Criteria:
- Moderate to severe obstructive sleep apnea
- Shift work;
- Other sleep/circadian disorders: e.g., circadian phase delay or phase advance;
restless legs syndrome, insomnia, narcolepsy, habitual sleep <6 hours/night
- Routinely ate within compressed time window in the past year (e.g., routinely eats all
food within an 10-hour or narrower window, follows an intermittent fasting protocol)
- Renal dysfunction (estimated Glomerular Filtration Rate (GFR) <30 using the simplified
Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) equation 34)
- Use of glucose-lowering medications, weight loss medications, medications for sleep
disorders (sedative/hypnotic drugs, stimulants), lithium, systemic corticosteroids,
diuretics, blood thinners requiring regular monitoring (e.g. warfarin), anti-psychotic
drugs and antiretroviral therapy
- Body weight >400 pounds (limitation of facility scales)
- >1 drink per day of alcohol
- Active substance use disorder or significant psychiatric/psychologic disorder that
would interfere with participation
- Significant food allergies, preferences, intolerances, or dietary supplements that
would interfere with diet adherence
- Weight loss or gain of ≥5% during past 6 months
- Pregnant, planning to become pregnant, or breastfeeding
- Planning to start a weight loss program
- Planning to leave the area prior to end of study
- Current participation in another clinical trial
- Cancer diagnosis requiring active treatment in past two years or planned treatment
(with exception of localized non-melanoma skin cancer)
- Active inflammatory bowel disease, malabsorption, or history of major gastrointestinal
surgery involving bowel resection
- Myocardial infarction or stroke in past 6 months
- Prior bariatric surgery
- Any serious illness that would interfere with participation
- Other conditions or situations at the discretion of the PI
We found this trial at
1
site
Click here to add this to my saved trials